Independent consultant Boston Healthcare Associates modelled the budget impact of using PromarkerD...
Clinical validation study confirms PromarkerD
Proteomics International announced today results from its validation clinical study showing that the PromarkerD blood test can predict the onset of diabetic kidney disease better than any current measure. These findings will be presented by Professor Tim Davis, from The University of Western Australia Medical School, at the American Diabetes Association’s 77th Annual Scientific Sessions (ADA), 9-13th June, in San Diego, California.
Click here to find out more about PromarkerD test.